Boundless Bio, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLD and other ETFs, options, and stocks.About BOLD
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F.
CEOZachary D. Hornby
CEOZachary D. Hornby
Employees64
Employees64
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees64
Employees64
BOLD Key Statistics
Market cap25.30M
Market cap25.30M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume168.98K
Average volume168.98K
High today$1.18
High today$1.18
Low today$1.12
Low today$1.12
Open price$1.16
Open price$1.16
Volume104.76K
Volume104.76K
52 Week high$3.12
52 Week high$3.12
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
As of today, Boundless Bio, Inc.(BOLD) shares are valued at $1.12. The company's market cap stands at 25.3M, with a P/E ratio of -0.41.
On 2025-12-16, Boundless Bio, Inc.(BOLD) stock moved within a range of $1.12 to $1.18. With shares now at $1.12, the stock is trading 0.0% above its intraday low and -5.0% below the session's peak.
Trading activity shows a volume of 104.76K, compared to an average daily volume of 168.98K.
The stock's 52-week range extends from a low of $1.00 to a high of $3.12.
The stock's 52-week range extends from a low of $1.00 to a high of $3.12.
People also own
Based on the portfolios of people who own BOLD. This list is generated using Robinhood data, and it’s not a recommendation.